心臟安全服務市場－全球產業規模、佔有率、趨勢、機會、預測：按服務、類型、最終用途、地區和競爭格局分類，2021-2031年

全球心臟安全服務市場預計將從 2025 年的 8.8313 億美元成長到 2031 年的 14.2652 億美元，複合年成長率為 8.32%。

這些服務包括由供應商在臨床試驗期間進行的專業心血管數據監測、收集和分析，例如心電圖和血壓測量，旨在識別潛在的藥物不良反應。推動該市場成長要素是全球心臟相關疾病負擔日益加重，以及美國食品藥物管理局 (FDA) 和歐洲藥品管理局 (EMA) 等衛生監管機構的嚴格監管要求，這些要求對新療法進行嚴謹的心血管風險評估。世界心臟聯盟 (WHF) 的報告顯示，到 2025 年，每年將有約 1800 萬人死於心血管疾病，凸顯了藥物研發過程中進行強力的安全監測的緊迫性。

市場促進因素

心臟安全服務市場的主要驅動力是臨床試驗營運外包給專業合約研究組織 (CRO) 的趨勢日益增強。隨著臨床試驗變得日益複雜且地理範圍更廣，生物製藥申辦方，尤其是規模較小的公司，越來越依賴 CRO 來管理跨越不同監管區域的複雜心血管監測。尤其是在新興生物製藥公司預計到 2024 年將佔所有臨床試驗的 63% 的背景下，這一趨勢更為顯著。同時，預計到 2024 年，生物製藥研發領域的巨額投資將達到 1,020 億美元，創下近十年來的最高水平，這將擴大基因療法和生物製藥等新型療法的研發管線。這些新治療方法通常涉及未知的心臟風險，需要持續、高精度的監測，因此推動了對貫穿整個藥物研發生命週期的全面心臟安全性測試的需求。

市場挑戰

全球心臟安全服務市場面臨許多挑戰，其中最主要的障礙在於，在跨國臨床實驗中心實施集中式安全監測的成本高且物流複雜。將臨床試驗擴展到不同的監管區域，會給數據收集標準化和專用設備的部署帶來沉重的經濟負擔，這對於缺乏資金應對複雜全球合規要求的中小型生物製藥公司而言尤其困難。這些運作障礙往往導致研究週期延長，用於詳細安全數據的預算減少，阻礙了全面心臟監測服務的廣泛應用。到2025年，35%的臨床研究中心將把試驗複雜性列為其面臨的最大營運挑戰，凸顯了在不同地區要求下實施穩健安全方案的難度。

市場趨勢

兩大關鍵趨勢正在重塑心臟安全方案：醫用級穿戴式連續監測設備的普及和人工智慧心電圖 (ECG) 分析的整合。穿戴式生物感測器能夠在傳統臨床試驗中心之外收集高度精確的真實世界數據，從而提供對心律不整風險的長期洞察，而這些風險可能被間歇性心電圖監測所忽略。 iRhythm Technologies 就是一個典型的例子，預計到 2024 年，該公司將透過其 Zio 平台為超過 200 萬名患者提供服務。同時，人工智慧心電圖分析對於管理來自連續監測的大量資料集至關重要。先進的機器學習演算法正在實現心血管安全終點分析的自動化，顯著提高診斷準確性並減輕中心審查團隊的人工工作量。例如，PMcardio 的人工智慧演算法在識別急性心臟事件方面達到了 92% 的準確率，顯著優於標準方法並大幅降低了誤報率。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球心臟安全服務市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 服務項目（心電圖/心電圖監測、血壓計、心血管影像等）
  • 按類型（整合式、獨立式）
  • 按最終用途（製藥和生物製藥公司、合約研究組織、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美心臟安全服務市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲心臟安全服務市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區心臟安全服務市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲心臟安全服務市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲心臟安全服務市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球心臟安全服務市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Medpace, Inc.
• IQVIA Holdings Inc.
• Thermo Fisher Scientific Inc.
• Charles River Laboratories International, Inc.
• WuXi AppTec Co., Ltd.
• Nova Research Laboratories LLC
• Laboratory Corporation of America Holdings
• Koninklije Philips NV
• ICON Plc
• Richmond Pharmacology Limited

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Cardiac Safety Services Market is projected to grow from USD 883.13 Million in 2025 to USD 1426.52 Million by 2031, at an 8.32% CAGR. These services involve specialized monitoring, collection, and analysis of cardiovascular data, such as ECGs and blood pressure readings, performed by vendors during clinical trials to identify potential adverse drug reactions. The market is primarily driven by stringent regulatory mandates from health authorities like the FDA and EMA for rigorous cardiovascular risk assessments in new therapeutics, alongside the increasing global burden of heart-related ailments; the World Heart Federation reported nearly 18 million annual cardiovascular-related deaths in 2025, emphasizing the urgent need for robust safety monitoring in drug development.

Market Driver

A primary catalyst for the cardiac safety services market is the accelerated outsourcing of clinical trial operations to specialized Contract Research Organizations (CROs). As clinical studies grow in complexity and geographical spread, biopharmaceutical sponsors, especially small to mid-sized entities, increasingly rely on CROs for managing intricate cardiovascular monitoring across diverse regulatory jurisdictions, particularly since emerging biopharma companies initiated 63% of all clinical trials in 2024. Simultaneously, substantial R&D investments in biopharmaceutical development, reaching a ten-year high of $102 billion in 2024, are expanding the pipeline of novel therapeutics like gene therapies and biologics. These new modalities often present unknown cardiac risk profiles, necessitating continuous, high-fidelity monitoring and thereby amplifying the demand for comprehensive cardiac safety testing throughout the drug development lifecycle.

Market Challenge

The Global Cardiac Safety Services Market faces a significant barrier due to the prohibitive costs and logistical complexities of implementing centralized safety monitoring across multinational trial sites. Expanding clinical studies into diverse regulatory jurisdictions imposes a substantial financial burden for standardizing data collection and deploying specialized equipment, proving particularly challenging for small and mid-sized biopharmaceutical organizations lacking the capital for intricate global compliance. These operational hurdles frequently extend study timelines and reduce budget allocation for detailed safety data, hindering the widespread adoption of comprehensive cardiac monitoring services; in 2025, 35% of clinical research sites identified increasing trial complexity as their leading operational challenge, underscoring the difficulties in executing robust safety protocols amidst varying local requirements.

Market Trends

Two pivotal trends are reshaping cardiac safety protocols: the proliferation of medical-grade wearable continuous monitoring devices and the integration of AI-driven ECG interpretation. Wearable biosensors enable high-fidelity, real-world data collection beyond traditional clinical sites, offering longitudinal insights into arrhythmogenic risks that episodic ECGs often miss, exemplified by iRhythm Technologies serving over 2 million patients with its Zio platform in 2024. Concurrently, AI-driven ECG interpretation is becoming essential for managing the vast datasets from continuous monitoring. Advanced machine learning algorithms automate the analysis of cardiovascular safety endpoints, significantly enhancing diagnostic precision and reducing the manual burden on central review teams. For instance, PMcardio's AI algorithm achieved 92% accuracy in identifying acute cardiac events, performing significantly better than standard methods and drastically reducing false alarms.

Key Market Players

• Medpace, Inc.
• IQVIA Holdings Inc.
• Thermo Fisher Scientific Inc.
• Charles River Laboratories International, Inc.
• WuXi AppTec Co., Ltd.
• Nova Research Laboratories LLC
• Laboratory Corporation of America Holdings
• Koninklije Philips N.V.
• ICON Plc
• Richmond Pharmacology Limited

Report Scope

In this report, the Global Cardiac Safety Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiac Safety Services Market, By Service

• ECG/Holter Monitors
• Blood Pressure Monitors
• Cardiovascular Imaging
• Others

Cardiac Safety Services Market, By Type

• Integrated
• Standalone

Cardiac Safety Services Market, By End Use

• Pharma & Biopharma Companies
• CROs
• Others

Cardiac Safety Services Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cardiac Safety Services Market.

Available Customizations:

Global Cardiac Safety Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cardiac Safety Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service (ECG/Holter Monitors, Blood Pressure Monitors, Cardiovascular Imaging, Others)
  • 5.2.2. By Type (Integrated, Standalone)
  • 5.2.3. By End Use (Pharma & Biopharma Companies, CROs, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Cardiac Safety Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service
  • 6.2.2. By Type
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cardiac Safety Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Cardiac Safety Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Cardiac Safety Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By End Use

7. Europe Cardiac Safety Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service
  • 7.2.2. By Type
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cardiac Safety Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Cardiac Safety Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Cardiac Safety Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Service
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Cardiac Safety Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Service
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Cardiac Safety Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Service
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By End Use

8. Asia Pacific Cardiac Safety Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service
  • 8.2.2. By Type
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Cardiac Safety Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Cardiac Safety Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Cardiac Safety Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Cardiac Safety Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Service
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Cardiac Safety Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Service
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Cardiac Safety Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service
  • 9.2.2. By Type
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Cardiac Safety Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Cardiac Safety Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Cardiac Safety Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By End Use

10. South America Cardiac Safety Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Service
  • 10.2.2. By Type
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cardiac Safety Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Service
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Cardiac Safety Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Service
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Cardiac Safety Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Service
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Cardiac Safety Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medpace, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. IQVIA Holdings Inc.
• 15.3. Thermo Fisher Scientific Inc.
• 15.4. Charles River Laboratories International, Inc.
• 15.5. WuXi AppTec Co., Ltd.
• 15.6. Nova Research Laboratories LLC
• 15.7. Laboratory Corporation of America Holdings
• 15.8. Koninklije Philips N.V.
• 15.9. ICON Plc
• 15.10. Richmond Pharmacology Limited

16. Strategic Recommendations

17. About Us & Disclaimer